J Vidaurre, S Gedela, S Yarosz - Pediatric Neurology, 2017 - Elsevier
Acute, symptomatic seizures or epilepsy may complicate the course of hepatic disease. Choosing the most appropriate antiepileptic drug in this setting represents a difficult …
T Fowler, AS Bansal, D Lozsádi - Seizure, 2019 - Elsevier
Adverse cutaneous reactions caused by mostly aromatic antiepileptic drugs (AED) affect 50.000 people a year in the United Kingdom (UK; incidence 75.7/100.000). Optimal …
L Stingeni, L Bianchi, M Tramontana… - Giornale Italiano di …, 2020 - air.unimi.it
Abstract Adverse Drug Reactions (ADRs) are common and influence negatively the patient's therapeutic options. They recognize multiple pathogenic mechanisms, some of …
P LaPenna, LM Tormoehlen - Journal of Medical Toxicology, 2017 - Springer
Epilepsy is a neurologic disorder affecting approximately 50 million people worldwide, or about 0.7% of the population [1]. Thus, the use of anticonvulsant drugs in the treatment of …
El eritema multiforme es un síndrome eruptivo agudo que se define por la morfología de las lesiones. Esta definición puramente clínica contribuye a una nosología todavía confusa. La …
M Milosavljević, SM Janković - Expert Opinion on Drug Safety, 2025 - Taylor & Francis
Introduction The third-generation antiseizure medications used for the treatment of focal seizures, lacosamide, eslicarbazepine acetate, perampanel, brivaracetam, and …
R Mani, A Almelegy, TM Truong, GN Pathak… - … Treatment Options in …, 2024 - Springer
Purpose of review This review describes risk factors for severe skin reactions to antiseizure medications (ASMs), the usage of updated tests to predict those with increased risk of a …
M Onodera, T Saito, A Fukui, M Nitta, S Tsuzuki… - Clinical Neurology and …, 2022 - Elsevier
Objective Antiseizure drug (ASD)-induced skin rash remains the main side effect of seizure management in patients with glioma. New generations of ASDs, such as levetiracetam (LEV) …